The Pentagon's new testosterone policy will strain the military health infrastructure
The mandatory testosterone screening initiated by the U.S. Department of Defense for its personnel detects low levels among tens of thousands of personnel, posing a significant risk of imposing a heavy monitoring and treatment burden on the military health system.
ASELSAN:
Lockheed Martin:
Rheinmetall:
BAE Systems:
Thales:
Leonardo:
Saab:
Kongsberg Gruppen:
Indra Sistemas:
Mitsubishi Heavy Ind.:
Hanwha Aerospace:
AVIC Shenyang Aircraft:
Hindustan Aeronautics: